Follow
Oscar Herrera-Restrepo
Oscar Herrera-Restrepo
PhD in Industrial and Systems Engineering, Virginia Tech
Verified email at vt.edu - Homepage
Title
Cited by
Cited by
Year
A Multi-perspective Dynamic Network Performance Measurement of an Evacuation: A Dynamic Network-DEA Approach.
O Herrera-Restrepo, K Triantis, J Trainor, P Murray-Tuite, P Edara
OMEGA The International Journal of Management Science, 2015
56*2015
Information Diffusion through Social Networks: the Case of an Online Petition
MS Jalali, A Ashouri, O Herrera-Restrepo, H Zhang
Expert Systems with Applications, 2015
542015
Information Diffusion through Social Networks: the Case of an Online Petition
M Jalali, A Ashoury, O Herrera-Restrepo, H Zhang
Proceedings of the 33rd International Conference of the System Dynamics …, 2015
542015
Bank Branch Operational Performance: A Robust Multivariate and Clustering Approach
O Herrera-Restrepo, K Triantis, WL Seaver, JC Paradi, H Zhu
Expert Systems with Applications, 2015
372015
Enterprise design through complex adaptive systems and efficiency measurement
O Herrera-Restrepo, K Triantis
European Journal of Operational Research 278 (2), 481-497, 2019
142019
Cost-effectiveness analysis of ado-trastuzumab emtansine (T-DM1) for the adjuvant treatment of patients with residual invasive HER2+ early breast cancer in the United States
J Sussell, GS Jhuti, V Antao, O Herrera-Restrepo, E Wehler, SP Bilir
American Journal of Clinical Oncology 44 (7), 340-349, 2021
132021
A budget impact and cost per additional responder analysis for baricitinib for the treatment of moderate-to-severe rheumatoid arthritis in patients with an inadequate response …
E Wehler, N Boytsov, C Nicolay, O Herrera-Restrepo, S Kowal
Pharmacoeconomics 38, 39-56, 2020
102020
PCN80 BUDGET IMPACT IN THE USA OF LIPOSOMAL IRINOTECAN AS A POST-GEMCITABINE TREATMENT OPTION FOR PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA (MPC)
O Herrera-Restrepo, C Ferrufino, SP Bilir, P Cockrum, A Valderrama
Value in Health 22, S70, 2019
72019
Cost-effectiveness of CPX-351 versus 7+ 3 regimen in the treatment of treatment-related acute myeloid leukemia (tAML) or AML with myelodysplasia-related changes (MRC)
A Kansal, M Du, O Herrera-Restrepo, R Leipold, RJ Ryan, AC Louie, ...
Blood 130, 4674, 2017
72017
Efficiency-driven enterprise design: A synthesis of studies
O Herrera-Restrepo, K Triantis
IEEE Transactions on Engineering Management 65 (3), 363-378, 2018
62018
Impact of pharmacist motivational interviewing on hepatitis B vaccination in adults with diabetes
LA Berenbrok, C Gessler, L Kirisci, O Herrera-Restrepo, KC Coley
Journal of the American Pharmacists Association 63 (1), 66-73. e1, 2023
52023
Health care providers’ knowledge, practices, and barriers to hepatitis vaccination guidelines
P Ghaswalla, K Davis, C Sweeney, E Davenport, A Trofa, ...
The Journal for Nurse Practitioners 18 (4), 403-410, 2022
42022
Virtual organizational design laboratory: Agent-based modeling of the co-evolution of social service delivery networks with population dynamics
O Herrera-Restrepo, A Medina-Borja
Expert Systems with Applications 98, 189-204, 2018
42018
159. Knowledge of invasive meningococcal disease and vaccination recommendations for adolescents and young adults among US physicians
O Herrera-Restrepo, S Bunniran, T Mond, E Davenport, J Wang, ...
Journal of Adolescent Health 72 (3), S89-S90, 2023
32023
160. Physician communication with patients/parents on menb vaccination for older adolescents and young adults
O Herrera-Restrepo, S Bunniran, T Mond, E Davenport, J Wang, ...
Journal of Adolescent Health 72 (3), S90, 2023
32023
Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices
O Herrera-Restrepo, K Davis, C Sweeney, E Davenport, P Ghaswalla, ...
Human Vaccines & Immunotherapeutics 18 (6), 2123180, 2022
32022
Determinants of meningococcal vaccination coverage and adherence: a targeted literature review supporting a 16-year-old healthcare visit
O Herrera-Restrepo, Y Kuang, J D’Angelo, R Bekkat-Berkani, ...
Infectious Diseases and Therapy 12 (5), 1265-1282, 2023
22023
A multi-agent framework for the co-evolution of social service delivery networks and population dynamics
OA Herrera-Restrepo, A Medina-Borja
Proceedings of the 2012 Industrial and Systems Engineering Research Conference, 2011
22011
The power of health economics and outcomes research (HEOR) in making decisions that matter
OH Restrepo
Magna Scientia UCEVA 1 (1), 25-33, 2021
12021
Cost-effectiveness of ado-trastuzumab emtansine (T-DM1) versus trastuzumab (H) for the adjuvant treatment of patients with residual invasive HER2+ early breast cancer in the US
HP Goertz, O Herrera-Restrepo, E Wehler, P Bilir, V Antao, GS Jhuti
CANCER RESEARCH 80 (4), 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20